Evidence map›Paper›PMID 21152913›Full record

ArticleEuropean biophysics journal : EBJ2011

Molecular dynamics of ribosomal elongation factors G and Tu.

Katarzyna Kulczycka, Maciej Długosz, Joanna Trylska

Open access · hybridAbstract read
In one paragraph

Article in European biophysics journal : EBJ, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Katarzyna KulczyckaInterdisciplinary Centre for Mathematical and Computational Modelling, University of Warsaw, Pawinskiego 5A, 02-106 Warsaw, Poland.
Maciej Długosz
Joanna Trylska
University of Warsaw · PL

Funding

ASSOCIATION OF ELONGATION FACTORS AND ANTIBIOTICS WITH THE RIBOSOMER03TW007318 · FIC · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI MCCAMMON, JAMES ANDREW · 2007 to 2009
$108k
FIC NIH HHS R03 TW007318
6 · The paper itself

Abstract

Translation on the ribosome is controlled by external factors. During polypeptide lengthening, elongation factors EF-Tu and EF-G consecutively interact with the bacterial ribosome. EF-Tu binds and delivers an aminoacyl-tRNA to the ribosomal A site and EF-G helps translocate the tRNAs between their binding sites after the peptide bond is formed. These processes occur at the expense of GTP. EF-Tu:tRNA and EF-G are of similar shape, share a common binding site, and undergo large conformational changes on interaction with the ribosome. To characterize the internal motion of these two elongation factors, we used 25 ns long all-atom molecular dynamics simulations. We observed enhanced mobility of EF-G domains III, IV, and V and of tRNA in the EF-Tu:tRNA complex. EF-Tu:GDP complex acquired a configuration different from that found in the crystal structure of EF-Tu with a GTP analogue, showing conformational changes in the switch I and II regions. The calculated electrostatic properties of elongation factors showed no global similarity even though matching electrostatic surface patches were found around the domain I that contacts the ribosome, and in the GDP/GTP binding region.

Indexed as

Molecular Dynamics SimulationBinding SitesGuanosine DiphosphateGuanosine TriphosphateModels, MolecularMotionPeptide Elongation Factor GPeptide Elongation Factor TuProtein BindingProtein BiosynthesisProtein ConformationRibosomesRNA, Transfer, Amino AcylThermusGuanosine DiphosphateGuanosine TriphosphatePeptide Elongation Factor GPeptide Elongation Factor TuRNA, Transfer, Amino Acyl

Identifiers

PMID21152913
PMCPMC3045518
OpenAlexW2042542349

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.